Why India did not allow Pfizer’s Covid-19 vaccine

Why India did not allow Pfizer’s Covid-19 vaccine

In Latin America pharmaceutical bullying went a notch higher. In addition to legal indemnity, Pfizer demanded protection against their own negligence and mistakes. Argentina amended its vaccine law, three times, yet Pfizer was not happy. Pfizer wanted Argentina’s bank reserves and military bases as “guarantees”.

In the era of neo-colonialism, Pharma industry was the new East India Company.

Despite such pressure, India did not succumb. Eventually, Pfizer withdrew its application in 2021 We continued our vaccine programme with drugs that complied with our legal requirements.

Beijing to Let Some Low-Risk Patients Home Quarantine as Covid Soars + Some Notes

Bloomberg: Beijing to Let Some Low-Risk Patients Home Quarantine as Covid Soars

Global Times: Flexible measures implemented across China to ensure people’s livelihoods amid cold front

China actually started relaxing it’s Zero-COVID polices on November 11th. The mNRA vaccine hasn’t been approved, yet. The West is pushing for China to use mNRA vaccines.

Related:

05-09-2022: Dropping zero-COVID policy in China without safeguards risks 1.5m lives – study

China’s refusal to use Western COVID-19 vaccines is making its protest problems even worse

Read More »

New COVID Booster Approved From Final Study of Mice, Not Humans, But Using Only Animal Data Is a Needless Gamble

VERIFY: New COVID booster approved from final study of mice, not humans

According to documents on the CDC website, human tests of Moderna’s version of the new booster are still “ongoing.” Right now, there is only final evidence from “8-10 mice” per group.”

The FDA’s website shows for Pfizer the agency also relayed on the final study evidence from “8 mice.” But human trials are also ongoing. So far, the new boosters “showed a similar local reaction and systemic event profile.” That means side effects appear to be about the same including “mild to moderate injection site pain, fatigue, and muscle pain.”

“To advance the Omicron BA.4/BA.5 bivalent vaccine as rapidly as possible, regulators, including the FDA, WHO and EMA, have advised that our submissions be based on safety and immunogenicity data generated in adults with an Omicron BA.1 bivalent vaccine and supported by BA.4/BA.5 bivalent pre-clinical data and BA.4/BA.5 bivalent quality and manufacturing data. These packages follow a similar model to that provided to public health officials who evaluate seasonal flu vaccines each year. Moving forward, this approach may help address the pressing need for vaccines that provide a high level of protection against current and emerging variants of concern so that we can remain vigilant against this evolving virus. The FDA has authorized our Omicron BA.4/BA.5 bivalent vaccine based on clinical data generated in adults with an Omicron BA.1 bivalent vaccine, pre-clinical data with a BA.4/BA.5 bivalent vaccine and BA.4/BA.5 bivalent quality and manufacturing data. Pre-clinical data showed a booster dose of Pfizer and BioNTech’s Omicron BA.4/BA.5- bivalent vaccine generated a strong neutralizing antibody response against Omicron BA.1, BA.2 and BA.4/BA.5 variants, as well as the original wild-type strain. A clinical study investigating the safety, tolerability and immunogenicity of the Omicron BA.4/BA.5 bivalent vaccine in individuals 12 years of age and older is ongoing. Data will be shared with regulators when available. We are facing a virus with an exceptionally high mutation rate, which the nimble mRNA platform is well situated to address. Only the mRNA sequence requires updating to match emerging strains, and utilizing a bivalent vaccine aims to provide broader coverage against known and future COVID-19 variants of concern.”

Related:

Read More »

Thai vaccine study

Video via Dr. John Campbell

References:

Cardiovascular Effects of the BNT162b2 mRNA COVID-19 Vaccine in Adolescents

Myocarditis and Sudden Cardiac Death in the Young

Incidence, risk factors, natural history, and hypothesised mechanisms of myocarditis and pericarditis following covid-19 vaccination: living evidence syntheses and review

CDC: Vaccines for COVID-19

CDC: COVID-19 Vaccines for Children and Teens

Related:

Vaccine myocarditis update from Thailand

Pfizer Jab Fails It’s CEO, Albert Bourla

The jab that failed on all counts BUT one.

The top executive at Pfizer, a leading producer of COVID-19 vaccines, has tested positive for the virus and says he is experiencing very mild symptoms.

Chairman and CEO Albert Bourla said Monday that he started taking Pfizer´s Paxlovid pill treatment and is isolating while he recovers.

Pfizer Jab Fails It’s CEO, Albert Bourla

Waiting for the Paxlovid Rebound…

Pfizer reportedly sponsored Miami yacht party for failed Colombian presidential contender Rodolfo Hernández

This article was originally published by Orinoco Tribune, June 18, 2022.

Editor’s note: Rodolfo Hernández, lauded in US mainstream media as an “anti-corruption” crusader, was defeated by left-wing politician Gustavo Petro in his bid for the presidency on June 19, 2022. Under the presidency of Ivan Duque, Colombia overpaid by as much as $375 million for Pfizer’s Covid-19 vaccine. According to secret contracts with Pfizer that were later leaked, Colombia was compelled by Pfizer to forfeit “immunity against precautionary seizure of any of [their state] assets.” A peer-reviewed May 2022 study by Jama Network Open found that “immunity against the omicron coronavirus variant fades rapidly after a second and third dose of Pfizer and BioNTech’s Covid-19 vaccine.”

Pfizer reportedly sponsored Miami yacht party for failed Colombian presidential contender Rodolfo Hernández

Biden Administration Makes Available 10 Million Doses of COVID Vaccine for Kids Under 5 — Before FDA Authorizes Shot

The Biden administration today said it made available 10 million doses of COVID-19 vaccines for children under age 5 to states and healthcare workers with “millions more available in the coming weeks.”

Biden Administration Makes Available 10 Million Doses of COVID Vaccine for Kids Under 5 — Before FDA Authorizes Shot

H/T: The Most Revolutionary Act